Ionis Pharmaceuticals Earnings Estimate
| IONS Stock | USD 42.37 0.42 1.00% |
Ionis Pharmaceuticals Revenue Breakdown by Earning Segment
By analyzing Ionis Pharmaceuticals' earnings estimates, investors can diagnose different trends across Ionis Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Ionis Pharmaceuticals' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 1.03 in 2025, whereas Pretax Profit Margin is likely to drop (0.69) in 2025. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Ionis Pharmaceuticals Earnings per Share Projection vs Actual
About Ionis Pharmaceuticals Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Ionis Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Ionis Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Ionis Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -2.2 B | -2.1 B | |
| Retained Earnings Total Equity | -1.3 B | -1.4 B | |
| Earnings Yield | (0.09) | (0.09) | |
| Price Earnings Ratio | (11.52) | (12.09) | |
| Price Earnings To Growth Ratio | (0.61) | (0.58) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.